Eolo Medical is an early stage company focused on therapies for advanced COPD treatment. They recently announced a major investment of over $7.1 million (50 Million Chinese Yuan) by China-based Yuexiu Financial Holdings and Ying Lan Capital. They are continuing their clinical studies of their proposed Type III implantable device for the treatment of advanced COPD, and investigating related pulmonary disease treatments using associated medical devices.